Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

GE HealthCare to Strengthen AI-Enabled Fetal Ultrasound

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Biotech Innovation Strengthening Clinical Pipelines

The discovery and development of next-generation therapies are being propelled by a fundamental leap in our understanding of molecular biology and cellular mechanics. By bridging the gap between laboratory research and clinical application, the life sciences sector is creating a robust stream of precision treatments that offer new hope for previously intractable conditions.

Hospital Infrastructure Modernization Shapes Healthcare

The physical environment in which care is delivered is evolving from a static container of services into an active, intelligent participant in the healing process. By prioritizing sustainability and integrating sophisticated facility management systems, modern medical institutions are enhancing their operational resilience while creating safer and more efficient spaces for both patients and clinicians.

Precision Diagnostics Accelerating Early Detection

The fundamental strategy of clinical medicine is shifting from managing symptoms to identifying the earliest molecular indicators of disease. By integrating sophisticated genomic analysis with high-fidelity imaging, practitioners are now able to intercept pathological processes long before they manifest as systemic illness, significantly improving the efficacy of therapeutic interventions.

GE HealthCare today announced a collaboration with Diagnoly to advance AI-enabled fetal ultrasound by integrating Diagnoly’s Fetoly solution into GE HealthCare’s Voluson women’s health ultrasound systems. The collaboration focuses on increasing reproducibility, efficiency and diagnostic confidence for prenatal screening exams.

An ultrasound examination is one of the most important tools physicians have to monitor fetal development and detect congenital abnormalities. However, fetal motion, maternal habitus, and user-dependency can adversely impact exam quality. By embedding AI-enabled fetal ultrasound tools into clinical workflows, the collaboration seeks to streamline examinations, reduce clinician workload, and support more standardized assessments.

“AI is redefining what’s possible in healthcare, and GE HealthCare is at the forefront of this movement, as an industry leader bringing AI-powered innovations to clinicians,” said Gerald Seifriedsberger, General Manager, Women’s Health Ultrasound, GE HealthCare. “This collaboration with Diagnoly further expands our ability to integrate advanced AI-based screening support into Voluson ultrasound, helping elevate care for women and their babies.”

Fetoly is a real-time AI solution aligned with International Society of Ultrasound in Obstetrics and Gynecology guidelines. It is designed to support fetal heart and brain analysis while continuously verifying exam completeness and quality criteria during scans, strengthening the Voluson portfolio for clinical use.

“Obstetric ultrasound remains one of the most powerful, but also complex imaging techniques. As a result, up to 50% of fetal abnormalities remain undetected during pregnancy,” said Ivan Voznyuk, Co-Founder and CEO of Diagnoly. “The integration of Fetoly into trusted Voluson ultrasound systems reflects our shared commitment to supporting clinicians in real-time with tools that can help improve maternal and fetal outcomes.”

Fetoly is U.S. Food and Drug Administration 510(k) cleared and CE marked. The AI application is available as a free trial through the Voluson Solution Store and major mobile app platforms.

MEDICAL FAIR ASIA 2026

Latest stories

Related stories

Biotech Innovation Strengthening Clinical Pipelines

The discovery and development of next-generation therapies are being propelled by a fundamental leap in our understanding of molecular biology and cellular mechanics. By bridging the gap between laboratory research and clinical application, the life sciences sector is creating a robust stream of precision treatments that offer new hope for previously intractable conditions.

Hospital Infrastructure Modernization Shapes Healthcare

The physical environment in which care is delivered is evolving from a static container of services into an active, intelligent participant in the healing process. By prioritizing sustainability and integrating sophisticated facility management systems, modern medical institutions are enhancing their operational resilience while creating safer and more efficient spaces for both patients and clinicians.

Precision Diagnostics Accelerating Early Detection

The fundamental strategy of clinical medicine is shifting from managing symptoms to identifying the earliest molecular indicators of disease. By integrating sophisticated genomic analysis with high-fidelity imaging, practitioners are now able to intercept pathological processes long before they manifest as systemic illness, significantly improving the efficacy of therapeutic interventions.

UK Medical Device Testing Jumps 17%, AI and Neurotech Lead

Clinical investigations of medical devices in the UK reached...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »